ORMP 241220 5.00C (ORMP241220C5000) Stock Options, News & Quotes

US OptionsDetailed Quotes

ORMP241220C5000

Watchlist

0.05
0.000.00%

15min DelayClose Nov 29 13:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Oramed Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
SECNov 7 16:10 ET · Announcements
Oramed Pharmaceuticals Reinforces Scilex Financial Ties
TipRanksOct 8 14:27 ET
Express News | Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
ReutersOct 7 10:00 ET
Press Release: Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
Dow JonesOct 7 10:00 ET
Sector Update: Health Care Stocks Decline Monday Afternoon
MT NewswiresSep 23 14:24 ET
Scilex Holding to Pay $2 Million to Oramed Pharmaceuticals in Loan Accord
MT NewswiresSep 23 13:46 ET

Comments

Jaguar8

Oct 7 09:01

NEWS tied with SCLX

$Oramed Pharmaceuticals (ORMP.US)$
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
NEW YORK, Oct. 7, 2024 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced the execution of definitive agreements for the restructuring of a portion of its existing Senior Secured Promissory Note from Scilex Holding Compa...